Canada Fabry Disease Treatment Market Size & Outlook
Canada fabry disease treatment market, 2016-2027 (US$M)
Related Markets
Canada fabry disease treatment market highlights
- The Canada fabry disease treatment market generated a revenue of USD 61.9 million in 2020 and is expected to reach USD 81.6 million by 2027.
- The Canada market is expected to grow at a CAGR of 4% from 2021 to 2027.
- In terms of segment, replagal was the largest revenue generating product in 2020.
- Lucerastat is the most lucrative product segment registering the fastest growth during the forecast period.
Fabry disease treatment market data book summary
| Market revenue in 2020 | USD 61.9 million |
| Market revenue in 2027 | USD 81.6 million |
| Growth rate | 4% (CAGR from 2020 to 2027) |
| Largest segment | Replagal |
| Fastest growing segment | Lucerastat |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Galafold, Fabrazyme, Replagal, Lucerastat |
| Key market players worldwide | 3D Systems Corp, Formlabs, Voxeljet AG ADR |
Other key industry trends
- In terms of revenue, Canada accounted for 5.1% of the global fabry disease treatment market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
- In North America, U.S. fabry disease treatment market is projected to lead the regional market in terms of revenue in 2027.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 718.2 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Fabry Disease Treatment Market Scope
Fabry Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada fabry disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fabry disease treatment market will help companies and investors design strategic landscapes.
Replagal was the largest segment with a revenue share of 53.8% in 2020. Horizon Databook has segmented the Canada fabry disease treatment market based on galafold, fabrazyme, replagal, lucerastat covering the revenue growth of each sub-segment from 2016 to 2027.
Reasons to subscribe to Canada fabry disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada fabry disease treatment market databook
-
Our clientele includes a mix of fabry disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada fabry disease treatment market , including forecasts for subscribers. This country databook contains high-level insights into Canada fabry disease treatment market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
Canada fabry disease treatment market size, by product, 2016-2027 (US$M)
Canada Fabry Disease Treatment Market Outlook Share, 2020 & 2027 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
